What We Published in March 2020

  1. Coller RJ, Berry JG, Kuo DZ, Kuhlthau K, Chung PJ, Perrin JM, Hoover CG,Warner G, Shelton C, Thompson LR, Garrity B, Stille CJ. Health System Research Priorities for Children and Youth With Special Health Care Needs.Pediatrics.2020 Mar;145(3).doi: 10.1542/peds.2019-0673.Epub 2020 Feb 5.PubMed PMID: 32024751.
  2. Goldberg JL, Navid F, Hank JA, Erbe AK, Santana V, Gan J, de Bie F, Javaid AM, Hoefges A, Merdler M, Carmichael L, Kim K, Bishop MW, Meager MM, Gillies SD, Pandey JP, Sondel PM. Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma. J Immunother Cancer. 2020 Mar;8(1). pii: e000590. doi: 10.1136/jitc-2020-000590. PMID:32169872
  3. Gusland DY, Livermore AT, Sterkel AK, Nguyen JC, Conway JH. Two Cases Illustrating the Diagnostic Challenge of Pediatric Blastomycosis Presenting as Osteomyelitis. Pediatr Emerg Care. 2020 Mar 19. doi: 10.1097/PEC.0000000000002084. [Epub ahead of print]. PubMed PMID: 32205801.
  4. Jenkins MC, Moreno MA. Vaccination Discussion among Parents on Social Media: A Content Analysis of Comments on Parenting Blogs. J Health Commun. 2020 Mar 10;1-11. doi: 10.1080/10810730.2020.1737761. [Epub ahead of print] PubMed PMID: 32154770.
  5. Kim M, Rao S, Eickhoff JC, DeSantes KB, Capitini CM. A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation. J Pediatr Hematol Oncol. 2020 Mar;42(2):145-148. doi: 10.1097/MPH.0000000000001422. PMID:30676436
  6. McBride JA, Sterkel AK, Matkovic E, Broman AT, Gibbons-Burgener SN, Gauthier GM. Clinical Manifestations and Outcomes in Immunocompetent and Immunocompromised Patients with Blastomycosis. Clin Infect Dis. 2020 Mar 17. Pii : ciaa276. doi: 10.1093/cid/ciaa276. [Epub ahead of print] PubMed PMID : 32179889.
  7. Mohr-Holland E, Reuter A, Furin J, Garcia-Prats A, De Azevedo V, Mudaly V, Kock Y, Trivino-Duran L, Isaakidis P, Hughes J. Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa. EClinicalMedicine.2020 Mar;20:100290.doi: 10.1016/j.eclinm.2020.100290.eCollection 2020 Mar.PubMed PMID: 32154506; PubMed Central PMCID: PMC7057194.
  8. Moreno MA, Hoopes AJ. (2019)Technology and Adolescent Health. Elsevier.
  9. Ryan MS, Kind T, Jirasevijinda TJ, Paul CR, Keeley MG, Rocha MEM. Propelling Educational Innovations to Publication in Five Steps. Academic Medicine. 3/3/20. Online ahead of print.doi: 10.1097/ACM.0000000000003275.
  10. Yang RK, Kuznetsov IB, Ranheim EA, Wei JS, Sindiri S, Gryder BE, Gangalapudi V, Song YK, Patel V, Hank JA, Zuleger CL, Erbe AK, Morris ZS, Quale R, Kim K, Albertini MR, Khan J, Sondel PM. Outcome-related signatures identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated After Starting Hu14.18-IL2. Clin Cancer Res. 2020 Mar 9. pii: clincanres.3294.2019. doi: 10.1158/1078-0432.CCR-19-3294. [Epub ahead of print] PMID:32152202